Postoperative Recurrent Vitreous Hemorrhage: Clinical Trials

1 trial for Postoperative Recurrent Vitreous Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1

Follow Postoperative Recurrent Vitreous Hemorrhage: new trials by email Literature Review of Postoperative Recurrent Vitreous Hemorrhage trials Research Report on Postoperative Recurrent Vitreous Hemorrhage

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy
Ranibizumab Injection, PPV - Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage
Phase 1UnknownTianjin Medical University Eye Hospital1202022-04-102022-08-12

Narrower conditions

Diabetic Retinopathy (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Angiopathies (1)  ·  Endocrine System Diseases (1)  ·  Eye Diseases (1)  ·  Retinal Diseases (1)  ·  Vascular Diseases (1)

Interventions

Ranibizumab (1)

Sponsors

Tianjin Medical University Eye Hospital (1)

Countries

China (1)